Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ErbB2/Her2 Antibody (4D5-8 (trastuzumab)) - Chimeric - Azide and BSA Free, Novus Biologicals™

Rabbit Monoclonal Antibody
$268.00 - $584.50
Specifications
Antigen | ErbB2/Her2 |
---|---|
Clone | 4D5-8 (trastuzumab) |
Dilution | Flow Cytometry 1:10 - 1:1000, ELISA 1:100 - 1:2000, Immunohistochemistry 1:10 - 1:500, CyTOF-ready |
Applications | Flow Cytometry, ELISA, Immunohistochemistry, CyTOF |
Classification | Monoclonal |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
NBP25263925
![]() |
Novus Biologicals
NBP2526390.025MG |
0.025 mg |
Each for $268.00
|
|
|||||
NBP25263902
![]() |
Novus Biologicals
NBP2526390.2MG |
0.2 mg |
Each for $584.50
|
|
|||||
Description
ErbB2/Her2 Monoclonal specifically detects ErbB2/Her2 in Human samples. It is validated for Flow Cytometry, ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, CyTOF-ready.Specifications
ErbB2/Her2 | |
Flow Cytometry 1:10 - 1:1000, ELISA 1:100 - 1:2000, Immunohistochemistry 1:10 - 1:500, CyTOF-ready | |
Monoclonal | |
Purified | |
RUO | |
Human | |
CD340, CD340 antigen, c-erb B2/neu protein, EC 2.7.10, EGFR2, HER-2, HER2EC 2.7.10.1, herstatin, Metastatic lymph node gene 19 protein, MLN 19, MLN19, NEUHER-2/neu, neuroblastoma/glioblastoma derived oncogene homolog, NGLTKR1, p185erbB2, Proto-oncogene c-ErbB-2, Proto-oncogene Neu, receptor tyrosine-protein kinase erbB-2, Tyrosine kinase-type cell surface receptor HER2, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2(neuro/glioblastoma derived oncogene homolog), v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastomaderived oncogene homolog (avian) | |
ERBB2 | |
IgG | |
Protein A or G purified | |
Oncogenic protein Her-2/neu (erbB-2), a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30% of invasive breast cancers and 70% of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder. |
4D5-8 (trastuzumab) | |
Flow Cytometry, ELISA, Immunohistochemistry, CyTOF | |
Unconjugated | |
Rabbit | |
Breast Cancer, Cancer, Cellular Markers, Core ESC Like Genes, Oncogenes, Protein Kinase, Stem Cell Markers, Tumor Suppressors | |
PBS with 0.02% Proclin 300. with 0.02% Proclin 300 | |
2064 | |
A431 cells (human epidermoid carcinoma) (over)expressing EGFR. | |
Primary | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title